---
edited: 2024-03-02
tags:
---
### Specifications

| Parameter                          | Specifications                                                                                                             |
| ---------------------------------- | -------------------------------------------------------------------------------------------------------------------------- |
| Type                               | Live attenuated                                                                                                            |
| Given at                           | 9 months                                                                                                                   |
| Dose                               | 0.5 mg                                                                                                                     |
| Route                              | Subcutaneous                                                                                                               |
| Duration                           | 15 y                                                                                                                       |
| ADRs                               |                                                                                                                            |
| Contraindications                  | [[immunocompromised status]]                                                                                               |
| Strain                             | Rubella: RA 27/3 strain                                                                                                    |
| Indications of<br> Rubella vaccine | 1st priority: Reproductive age group females<br>2nd priority: Pre-teenage age groups<br>3rd priority: Routine immunization |


---
